25,900 Shares in The Beauty Health Company $SKIN Purchased by Simplicity Wealth LLC

Simplicity Wealth LLC acquired a new position in shares of The Beauty Health Company (NASDAQ:SKIN) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 25,900 shares of the company’s stock, valued at approximately $49,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Prescott Group Capital Management L.L.C. increased its position in Beauty Health by 47.0% during the first quarter. Prescott Group Capital Management L.L.C. now owns 646,798 shares of the company’s stock worth $867,000 after purchasing an additional 206,798 shares during the last quarter. Goldman Sachs Group Inc. increased its position in Beauty Health by 5.0% during the first quarter. Goldman Sachs Group Inc. now owns 665,706 shares of the company’s stock worth $892,000 after purchasing an additional 31,880 shares during the last quarter. SCS Capital Management LLC acquired a new stake in Beauty Health during the first quarter worth about $67,000. Nuveen LLC acquired a new stake in Beauty Health during the first quarter worth about $59,000. Finally, Newman Dignan & Sheerar Inc. increased its position in Beauty Health by 28.1% during the second quarter. Newman Dignan & Sheerar Inc. now owns 91,144 shares of the company’s stock worth $174,000 after purchasing an additional 20,000 shares during the last quarter. 93.26% of the stock is currently owned by institutional investors and hedge funds.

Beauty Health Trading Up 3.0%

NASDAQ SKIN opened at $1.70 on Thursday. The firm has a 50 day simple moving average of $2.05 and a 200-day simple moving average of $1.70. The company has a debt-to-equity ratio of 4.91, a quick ratio of 4.15 and a current ratio of 5.15. The Beauty Health Company has a one year low of $0.78 and a one year high of $2.69. The firm has a market cap of $215.59 million, a price-to-earnings ratio of -6.07 and a beta of 1.21.

Beauty Health (NASDAQ:SKIN) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.06) by $0.09. Beauty Health had a negative net margin of 6.13% and a negative return on equity of 32.82%. The business had revenue of $78.20 million during the quarter, compared to analyst estimates of $74.67 million. Beauty Health has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts anticipate that The Beauty Health Company will post -0.25 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on SKIN shares. TD Cowen raised their price objective on shares of Beauty Health from $2.00 to $2.50 and gave the stock a “hold” rating in a research report on Monday, September 22nd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Beauty Health in a research note on Wednesday. Stifel Nicolaus increased their target price on shares of Beauty Health from $3.00 to $4.00 and gave the stock a “hold” rating in a research note on Friday, August 1st. Cowen reaffirmed a “hold” rating on shares of Beauty Health in a research note on Monday, September 22nd. Finally, Wall Street Zen raised shares of Beauty Health from a “hold” rating to a “buy” rating in a research note on Saturday, August 9th. One equities research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $2.81.

Beauty Health Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.